OTCMKTS:PBSVPharma Bio Serv Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Pharma Bio Serv Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.85 +0.01 (+1.19 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range$0.85Now: $0.85▼$0.8550-Day Range$0.82MA: $0.85▼$0.8752-Week Range$0.60Now: $0.85▼$1.15Volume3,677 shsAverage Volume4,138 shsMarket Capitalization$19.90 millionP/E Ratio9.45Dividend Yield8.93%Beta0.23 ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Pharma Bio Serv. Previous Next 2.3 Community Rank Outperform VotesPharma Bio Serv has received 116 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPharma Bio Serv has received 132 “underperform” votes. (Add your “underperform” vote.)Community SentimentPharma Bio Serv has received 53.23% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Pharma Bio Serv and other stocks. Vote “Outperform” if you believe PBSV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PBSV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend LeadershipPharma Bio Serv is a leading dividend payer. It pays a dividend yield of 8.93%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthPharma Bio Serv does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Pharma Bio Serv is 88.89 %. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Pharma Bio Serv will have a dividend payout ratio of 50.00 % next year. This indicates that Pharma Bio Serv will be able to sustain or increase its dividend. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Pharma Bio Serv insiders have not sold or bought any company stock.Percentage Held by Insiders51.40% of the stock of Pharma Bio Serv is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Pharma Bio Serv are expected to grow by 23.08% in the coming year, from $0.13 to $0.16 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Pharma Bio Serv is 9.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.84.Price to Earnings Ratio vs. SectorThe P/E ratio of Pharma Bio Serv is 9.45, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 19.95.Price to Book Value per Share RatioPharma Bio Serv has a P/B Ratio of 0.97. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.79 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Management consulting services Sub-IndustryN/A SectorBusiness Services Current SymbolOTCMKTS:PBSV Previous Symbol CUSIPN/A CIK1304161 Webwww.pharmabioserv.com Phone787-278-2709Debt Debt-to-Equity RatioN/A Current Ratio12.66 Quick Ratio12.66Price-To-Earnings Trailing P/E Ratio9.45 Forward P/E Ratio6.54 P/E GrowthN/A Sales & Book Value Annual Sales$19.51 million Price / Sales1.02 Cash Flow$0.09 per share Price / Cash Flow8.99 Book Value$0.88 per share Price / Book0.97Profitability EPS (Most Recent Fiscal Year)$0.09 Net Income$2.09 million Net Margins10.97% Return on Equity10.10% Return on Assets8.19%Miscellaneous Employees185 Outstanding Shares23,410,000Market Cap$19.90 million Next Earnings Date6/12/2020 (Estimated) OptionableNot Optionable OTC:PBSV Rates by TradingView Receive PBSV News and Ratings via Email Sign-up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Pharma Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions How has Pharma Bio Serv's stock been impacted by COVID-19 (Coronavirus)? Pharma Bio Serv's stock was trading at $0.85 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PBSV stock has increased by 0.0% and is now trading at $0.85. View which stocks have been most impacted by Coronavirus. When is Pharma Bio Serv's next earnings date? Pharma Bio Serv is scheduled to release its next quarterly earnings announcement on Friday, June 12th 2020. View our earnings forecast for Pharma Bio Serv. How were Pharma Bio Serv's earnings last quarter? Pharma Bio Serv Inc (OTCMKTS:PBSV) announced its quarterly earnings results on Monday, March, 16th. The company reported $0.02 EPS for the quarter. The company earned $4.61 million during the quarter. Pharma Bio Serv had a return on equity of 10.10% and a net margin of 10.97%. View Pharma Bio Serv's earnings history. Has Pharma Bio Serv been receiving favorable news coverage? News stories about PBSV stock have been trending positive recently, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pharma Bio Serv earned a media sentiment score of 2.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutPharma Bio Serv. Who are some of Pharma Bio Serv's key competitors? Some companies that are related to Pharma Bio Serv include ATIF (ATIF), Wilhelmina International (WHLM), Lightbridge (LTBR), TSS (TSSI), China Internet Nationwide Fncl Srvcs (CIFS), Digipath (DIGP), Gopher Protocol (GOPH), China Xingbang Industry Group (CXGP), CleanTech Innovations (SIXD), HPIL (HPIL) and Transatlantic Capital (TACI). View all competitors. What other stocks do shareholders of Pharma Bio Serv own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), Aeglea Bio Therapeutics (AGLE), AstroNova (ALOT), Ampliphi Biosciences (APHB), Earthstone Energy (ESTE), Mondelez International (MDLZ), Oracle (ORCL), Lendingtree (TREE) and Transcat (TRNS). Who are Pharma Bio Serv's key executives? Pharma Bio Serv's management team includes the following people: Ms. Elizabeth Plaza, Founder, Chairman & Sr. Strategic Consultant (Age 55)Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 48)Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin. and Sec. (Age 59) What is Pharma Bio Serv's stock symbol? Pharma Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV." How do I buy shares of Pharma Bio Serv? Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Pharma Bio Serv's stock price today? One share of PBSV stock can currently be purchased for approximately $0.85. How big of a company is Pharma Bio Serv? Pharma Bio Serv has a market capitalization of $19.90 million and generates $19.51 million in revenue each year. The company earns $2.09 million in net income (profit) each year or $0.09 on an earnings per share basis. Pharma Bio Serv employs 185 workers across the globe. What is Pharma Bio Serv's official website? The official website for Pharma Bio Serv is www.pharmabioserv.com. How can I contact Pharma Bio Serv? Pharma Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at 787-278-2709 or via email at [email protected] This page was last updated on 6/6/2020 by MarketBeat.com Staff
